Mark T. Skoog

1.1k total citations · 1 hit paper
17 papers, 952 citations indexed

About

Mark T. Skoog is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Mark T. Skoog has authored 17 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Mark T. Skoog's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and Chemical Synthesis and Analysis (3 papers). Mark T. Skoog is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers) and Chemical Synthesis and Analysis (3 papers). Mark T. Skoog collaborates with scholars based in United States and Brazil. Mark T. Skoog's co-authors include William P. Jencks, Cheng-Kon Shih, Vincent J. Merluzzi, Karl D. Hargrave, Mark E. Labadia, Karl Grozinger, Joseph C. Wu, Robert J. Eckner, John L. Sullivan and Susan E. Hattox and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Mark T. Skoog

17 papers receiving 899 citations

Hit Papers

Inhibition of HIV-1 Replication by a Nonnucleoside Revers... 1990 2026 2002 2014 1990 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark T. Skoog United States 10 567 501 344 327 116 17 952
Tsutomu Mimoto Japan 13 475 0.8× 388 0.8× 427 1.2× 325 1.0× 54 0.5× 20 878
Richard Hazen United States 20 879 1.6× 687 1.4× 516 1.5× 441 1.3× 275 2.4× 36 1.5k
Noriyuki Ashida Japan 17 418 0.7× 252 0.5× 378 1.1× 326 1.0× 178 1.5× 53 976
Kurt Weaver United States 15 770 1.4× 645 1.3× 557 1.6× 245 0.7× 192 1.7× 17 1.2k
Roger Guedj France 18 366 0.6× 199 0.4× 508 1.5× 544 1.7× 103 0.9× 60 1.1k
Sally Redshaw United Kingdom 11 715 1.3× 594 1.2× 503 1.5× 376 1.1× 104 0.9× 26 1.3k
Tai Shun Lin United States 15 395 0.7× 207 0.4× 441 1.3× 420 1.3× 136 1.2× 24 887
James P. Guare United States 14 432 0.8× 369 0.7× 425 1.2× 546 1.7× 81 0.7× 32 1.1k
Issei Nitta Japan 14 565 1.0× 424 0.8× 274 0.8× 361 1.1× 124 1.1× 28 941
Karl Grozinger United States 14 770 1.4× 619 1.2× 439 1.3× 664 2.0× 156 1.3× 34 1.4k

Countries citing papers authored by Mark T. Skoog

Since Specialization
Citations

This map shows the geographic impact of Mark T. Skoog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Skoog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Skoog more than expected).

Fields of papers citing papers by Mark T. Skoog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Skoog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Skoog. The network helps show where Mark T. Skoog may publish in the future.

Co-authorship network of co-authors of Mark T. Skoog

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Skoog. A scholar is included among the top collaborators of Mark T. Skoog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Skoog. Mark T. Skoog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ahmad, Saleem, Masud Alam, Gregory S. Bisacchi, et al.. (1995). α-hydroxyamide derived aminodiols as potent inhibitors of hiv protease. Bioorganic & Medicinal Chemistry Letters. 5(15). 1729–1734. 9 indexed citations
2.
Hopkins, Jerry L., et al.. (1993). Rapid, sensitive and efficient HPLC assays for HIV-1 proteinase. Journal of Biochemical and Biophysical Methods. 27(3). 191–197. 7 indexed citations
3.
Alam, Masud, Clifford Bechtold, Amy K. Patick, et al.. (1993). Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitors. Antiviral Research. 22(2-3). 131–141. 9 indexed citations
4.
Skiles, Jerry W., Clara K. Miao, Ronald Sorcek, et al.. (1992). Inhibition of human leukocyte elastase by N-substituted peptides containing .alpha.,.alpha.-difluorostatone residues at P1. Journal of Medicinal Chemistry. 35(26). 4795–4808. 19 indexed citations
5.
Skoog, Mark T., et al.. (1992). Inhibition of HIV‐1 reverse transcriptase and virus replication by a non‐nucleoside dipyridodiazepinone BI‐RG‐587 (nevirapine). Medicinal Research Reviews. 12(1). 27–40. 16 indexed citations
6.
Kopp, Elizabeth B., et al.. (1991). Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template. Nucleic Acids Research. 19(11). 3035–3039. 47 indexed citations
7.
Pallai, Peter V., et al.. (1991). Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay. Journal of Biochemical and Biophysical Methods. 23(2). 107–113. 8 indexed citations
8.
Merluzzi, Vincent J., Karl D. Hargrave, Mark E. Labadia, et al.. (1990). Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor. Science. 250(4986). 1411–1413. 653 indexed citations breakdown →
9.
Skoog, Mark T., Shujaath Mehdi, Jeffrey S. Wiseman, & Philippe Bey. (1989). The specificity of two proteinases that cleave adjacent to arginine, Cl esterase and acrosin, for peptide p-nitroanilide substrates. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 996(1-2). 89–94. 4 indexed citations
10.
Weintraub, Philip M., Mark T. Skoog, James S. Nichols, et al.. (1989). Inhibition of 5-Lipoxygenase by Substituted 3,4-Dihydro-2H-1,4-thiazines. Journal of Pharmaceutical Sciences. 78(11). 937–943. 4 indexed citations
11.
Wiseman, Jeffrey S., et al.. (1988). Activity of soybean lipoxygenase in the absence of lipid hydroperoxide. Biochemistry. 27(24). 8810–8813. 11 indexed citations
12.
Skoog, Mark T., James S. Nichols, Boyd L. Harrison, & Jeffrey S. Wiseman. (1988). Specificity of an HPETE peroxidase from rat PMN. Prostaglandins. 36(3). 373–384. 3 indexed citations
13.
Wiseman, Jeffrey S., Mark T. Skoog, James S. Nichols, & Boyd L. Harrison. (1987). Kinetics of leukotriene A4 synthesis by 5-lipoxygenase from rat polymorphonuclear leukocytes. Biochemistry. 26(18). 5684–5689. 21 indexed citations
14.
Skoog, Mark T., James S. Nichols, Boyd L. Harrison, & Jeffrey S. Wiseman. (1986). Glutathione peroxidase is neither required nor kinetically competent for conversion of 5-HPETE to 5-HETE in rat PMN lysates. Prostaglandins. 31(3). 577–593. 14 indexed citations
15.
Skoog, Mark T., James S. Nichols, & Jeffrey S. Wiseman. (1986). 5-Lipoxygenase from rat PMN lysate. Prostaglandins. 31(3). 561–576. 23 indexed citations
16.
Skoog, Mark T. & William P. Jencks. (1984). Reactions of pyridines and primary amines with N-phosphorylated pyridines. Journal of the American Chemical Society. 106(24). 7597–7606. 86 indexed citations
17.
Skoog, Mark T. & William P. Jencks. (1983). Phosphoryl transfer between pyridines. Journal of the American Chemical Society. 105(10). 3356–3357. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026